Objective: Axillary lymph node dissection (ALND) may be unnecessary in 20%–60% of breast
cancer patients with sentinel lymph node (NSLN) metastasis. The aim of the present study …

Various novel HER2-targeted antibody-conjugated drugs (ADCs) have shown satisfactory
antitumor activity in HER2-low-positive breast cancer (BC). It is urgent to clarify whether HER2-…

Background Breast cancer is the most common cancer among women worldwide. Here, we
report the prevalence of BRCA1/2 mutations in patients with high‐risk breast cancer from …

Background: In the era of targeted therapy, whether patients with human epidermal growth
factor receptor 2 (HER2)-positive breast cancer are exempted from anthracycline usage in the …

Purpose The prediction of axillary lymph node status after neoadjuvant chemotherapy (NAC)
becoming critical because of the advocation of the de-escalation of axillary management. …

To the Editor: In the last decade, neoadjuvant chemotherapy (NAC) has become a well-accepted
treatment option for breast cancer, although few detailed description of NAC in China …

Sentinel lymph node biopsy (SLNB) is a standard procedure used to evaluate the status of
axillary lymph nodes (ALNs) that are clinically tumor-free in patients with early-stage breast …

Downstaging of breast cancer primary lesions and metastatic axillary lymph nodes among
patients who underwent neoadjuvant chemotherapy (NAC) has raised the new challenges …

We investigated the factors associated with pathologic node negativity (ypN0) in patients who
received neoadjuvant chemotherapy (NAC) to develop and validate an accurate prediction …

Introduction: Breast carcinosarcoma is an extremely rare breast tumor comprising two
distinct components, a carcinomatous component and a non-epithelial component of …